Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each These subcutaneous examples come from informal research discussions
1 Averill-Bates DA
Immunomagnetic delivery of adipose-derived endothelial progenitor cells for the repair of renal ischemia-reperfusion injury in a rat model
Dixon et al., GST genes were shown to be strongly inducible by the key defense hormone salicylic acid (SA) (Fodor et al., 1997
PMID: 38394858
